| P2093 | author name string | Kazuaki Takabe | |
| | Masayuki Nagahashi | |
| | Satoshi Watanabe | |
| | Toshifumi Wakai | |
| | Kizuki Yuza | |
| P2860 | cites work | Comparison of next-generation sequencing systems | Q21296690 |
| | Mutational heterogeneity in cancer and the search for new cancer-associated genes | Q24606956 |
| | Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas | Q24617520 |
| | Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability | Q24618618 |
| | Current and emerging therapies in unresectable and recurrent gastric cancer | Q26745453 |
| | Deficient mismatch repair: Read all about it (Review) | Q26796491 |
| | Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency. | Q27853362 |
| | Improved Survival with Ipilimumab in Patients with Metastatic Melanoma | Q27861062 |
| | Molecular profiling of biliary tract cancer: a target rich disease | Q28072275 |
| | Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases | Q28247135 |
| | Hypermutation in human cancer genomes: footprints and mechanisms | Q28255066 |
| | Hypermutation takes the driver's seat | Q28259671 |
| | PD-1 Blockade in Tumors with Mismatch-Repair Deficiency | Q28262647 |
| | A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer | Q28289377 |
| | Integrated genomic characterization of endometrial carcinoma | Q28289962 |
| | Systematic review of microsatellite instability and colorectal cancer prognosis | Q28303189 |
| | Hypermutation and unique mutational signatures of occupational cholangiocarcinoma in printing workers exposed to haloalkanes | Q28828382 |
| | Signatures of mutational processes in human cancer | Q29547191 |
| | Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer | Q29615679 |
| | Negative hMSH2 protein expression in pancreatic carcinoma may predict a better prognosis of patients. | Q64959289 |
| | Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from | Q73119476 |
| | Microsatellite instability in gallbladder carcinoma: two independent genetic pathways of gallbladder carcinogenesis | Q73152383 |
| | Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer | Q73345126 |
| | Infrequent microsatellite instability in biliary tract cancer | Q73552697 |
| | Methylation of the hMLH1 promoter but no hMLH1 mutations in sporadic gastric carcinomas with high-level microsatellite instability | Q73911349 |
| | Cancers of the papilla of vater: mutator phenotype is associated with good prognosis | Q77553516 |
| | hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability | Q77804814 |
| | K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China | Q78358414 |
| | Lack of microsatellite instability in neoplasms of ampulla of Vater | Q79095318 |
| | Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability | Q80676354 |
| | Microsatellite instability in solitary and sporadic gastric cancer | Q81006243 |
| | Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma | Q81383354 |
| | Defective DNA mismatch repair in long-term (> or =3 years) survivors with pancreatic cancer | Q81691515 |
| | Microsatellite instability in hepatocellular carcinoma in non-cirrhotic liver in patients older than 60 years | Q82826116 |
| | DNA mismatch repair deficiency in ampullary carcinoma: a morphologic and immunohistochemical study of 54 cases | Q84068763 |
| | Genetic basis for clinical response to CTLA-4 blockade in melanoma | Q29620594 |
| | Microsatellite instability in cancer of the proximal colon | Q29620692 |
| | Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer | Q29620902 |
| | Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder. | Q31146348 |
| | Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients | Q33552813 |
| | Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer | Q33586020 |
| | The potential role of comprehensive genomic profiling to guide targeted therapy for patients with biliary cancer | Q33656860 |
| | Whole-genome reconstruction and mutational signatures in gastric cancer. | Q33751188 |
| | The Feasibility and Safety of Surgery in Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Study. | Q33785811 |
| | Irrelevance of microsatellite instability in the epidemiology of sporadic pancreatic ductal adenocarcinoma | Q34430572 |
| | The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints | Q34943776 |
| | The microsatellite instable subset of colorectal cancer is a particularly good candidate for checkpoint blockade immunotherapy | Q34970884 |
| | Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China | Q35010949 |
| | Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy | Q35224176 |
| | Applicability of next generation sequencing technology in microsatellite instability testing | Q35227758 |
| | Clinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer. | Q35677409 |
| | Microsatellite instability and survival in gastric cancer: A systematic review and meta-analysis | Q35753579 |
| | Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+ | Q35765148 |
| | Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway | Q35788845 |
| | Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity | Q35810149 |
| | Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. | Q35833733 |
| | Biliary carcinomas: pathology and the role of DNA mismatch repair deficiency. | Q36187672 |
| | Review of genetic and epigenetic alterations in hepatocarcinogenesis | Q36481178 |
| | Clinicopathological and molecular alterations in early gastric cancers with the microsatellite instability-high phenotype | Q36536744 |
| | Microsatellite instability status in gastric cancer: a reappraisal of its clinical significance and relationship with mucin phenotypes | Q36660380 |
| | Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis | Q36670779 |
| | DNA polymerases and cancer. | Q37084895 |
| | Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary | Q37169725 |
| | Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade | Q37173548 |
| | An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers | Q37211712 |
| | Genomic correlates of response to CTLA-4 blockade in metastatic melanoma | Q37319470 |
| | Clinicopathologic Characteristics of Microsatellite Instable Gastric Carcinomas Revisited: Urgent Need for Standardization | Q37488484 |
| | Clinical Significance and Prognostic Relevance of Microsatellite Instability in Sporadic Colorectal Cancer Patients. | Q37631539 |
| | Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy | Q37718250 |
| | The analysis of microsatellite instability in extracolonic gastrointestinal malignancy. | Q38135726 |
| | Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. | Q38307191 |
| | Microsatellite instability and loss of heterozygosity at DNA mismatch repair gene loci occurs during hepatic carcinogenesis | Q38471628 |
| | 1,2-Dichloropropane generates phosphorylated histone H2AX via cytochrome P450 2E1-mediated metabolism | Q38712074 |
| | Polymerase proofreading domain mutations: New opportunities for immunotherapy in hypermutated colorectal cancer beyond MMR deficiency | Q38828156 |
| | The emerging role of immunotherapy in gastric and esophageal adenocarcinoma | Q38831655 |
| | Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer | Q38868401 |
| | Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine. | Q39071381 |
| | Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor | Q40409619 |
| | Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing. | Q40468182 |
| | Parasite-associated morbidity: liver fluke infection and bile duct cancer in northeast Thailand. | Q40645140 |
| | Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability | Q40921835 |
| | Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma | Q41316099 |
| | Microsatellite instability in gallbladder carcinoma | Q41438298 |
| | Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features | Q41668427 |
| | Microsatellite instability and p53 mutations in hepatocellular carcinoma. | Q42997151 |
| | Distinct clinical features and outcomes of gastric cancers with microsatellite instability | Q44028985 |
| | Epigenetic and genetic alterations in duodenal carcinomas are distinct from biliary and ampullary carcinomas. | Q44429799 |
| | Microsatellite instability mutator phenotype in hepatocellular carcinoma in non-alcoholic and non-virally infected normal livers. | Q44680926 |
| | Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers | Q45704144 |
| | Microsatellite instability detection by next generation sequencing | Q45790131 |
| | Chemosensitivity and survival in gastric cancer patients with microsatellite instability. | Q45946943 |
| | Hypermutation In Pancreatic Cancer | Q46267270 |
| | Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features, and long-term survival | Q46623690 |
| | Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy | Q46958955 |
| | Pancreatic mucinous noncystic (colloid) carcinomas and intraductal papillary mucinous carcinomas are usually microsatellite stable. | Q47830094 |
| | Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy. | Q47903730 |
| | Microsatellite instability is associated with a better prognosis for gastric cancer patients after curative surgery | Q48667067 |
| | Influence of GSH S-transferase on the mutagenicity induced by dichloromethane and 1,2-dichloropropane | Q49950941 |
| | Microsatellite Instability in Chronic Cholecystitis Is Indicative of an Early Stage in Gallbladder Carcinogenesis | Q50172278 |
| | BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage. | Q50853051 |
| | Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. | Q50893078 |
| | Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection. | Q51417165 |
| | High microsatellite instability predicts good prognosis in intestinal-type gastric cancers. | Q51503013 |
| | Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions. | Q51791931 |
| | Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers. | Q51814746 |
| | Adjunctive Therapy of Gastric Cancer: Moving the Field Forward. | Q53150075 |
| | Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy. | Q53200151 |
| | Genomic spectra of biliary tract cancer. | Q53390123 |
| | Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. | Q53399548 |
| | Infrequent widespread microsatellite instability in hepatocellular carcinomas. | Q53413539 |
| | Analysis of LKB1 mutations and other molecular alterations in pancreatic acinar cell carcinoma. | Q54373054 |
| | Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy | Q57567897 |
| | Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability | Q57978015 |
| P433 | issue | 67 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microsatellite | Q265193 |
| P304 | page(s) | 112103-112115 | |
| P577 | publication date | 2017-12-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Hypermutation and microsatellite instability in gastrointestinal cancers | |
| P478 | volume | 8 | |